Can molecular markers improve over traditional grading for oral potentially malignant disorders?
Oral potentially malignant disorders (OPMD) are a group of conditions in the mouth that have a varying but significant risk of turning into oral squamous cell carcinoma (cancer). Because these lesions are biologically complex, predicting which ones will become cancerous is a major challenge for doctors.
Traditional methods, such as histopathological grading (examining tissue under a microscope), may not always be reliable enough to predict the exact risk of cancer. Research suggests that moving toward molecularly informed assessments can provide a more accurate way to evaluate these risks.
What the research says
Current research indicates that traditional morphology-based diagnostics have limitations because OPMD progression is a dynamic process involving genetic changes and environmental factors 3. Molecular markers may offer a better way to assess risk by identifying specific signaling pathways, such as TGF-β or PI3K/AKT, which contribute to how cells behave and evade the immune system 3.
Specific molecular indicators are being studied for their potential in predicting cancer. For example, the PD-1/PD-L1 axis (a part of the immune system) shows promise as a marker for predicting if an OPMD will turn into cancer, though more clinical trials are needed to confirm its use 2. Additionally, large-scale data analysis has identified specific gene patterns related to DNA replication and cell adhesion that change as lesions move from low-risk to high-grade dysplasia 4.
While molecular markers are promising, other technologies are also being explored to improve diagnosis. These include artificial intelligence (AI) models that analyze digital photos to identify OPMDs and specialized tools like VELscope to increase detection accuracy [1, 5].
What to ask your doctor
- How do you currently grade my oral lesion, and what are the limitations of using only visual or microscopic changes?
- Are there specific molecular markers or biomarkers that can help determine if my condition is likely to progress to cancer?
- What role does the immune environment play in the progression of my specific type of lesion?
- Are there advanced imaging or AI-assisted tools available to help monitor my condition more accurately?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.